Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2023

Boscogen Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for BOSCOGEN, and what generic and branded alternatives to BOSCOGEN drugs are available?

BOSCOGEN has five approved drugs.

Summary for Boscogen

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5

Drugs and US Patents for Boscogen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boscogen	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	091279-005	Jan 9, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Boscogen	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	091279-003	Jan 9, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Boscogen	REPAGLINIDE	repaglinide	TABLET;ORAL	091517-002	Apr 24, 2015		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Boscogen	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	091279-006	Jan 9, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Boscogen	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	091279-002	Jan 9, 2017	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Boscogen	CAPTOPRIL	captopril	TABLET;ORAL	074677-003	May 30, 1997	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Boscogen

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

McKesson

Johnson and Johnson

Baxter

AstraZeneca

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.